Članki z zahtevami za javni dostop - Joke BilckeVeč o tem
Ni na voljo nikjer: 5
Rotavirus disease and vaccination: impact on genotype diversity
J Matthijnssens, J Bilcke, M Ciarlet, V Martella, K Bányai, M Rahman, ...
Future microbiology 4 (10), 1303-1316, 2009
Zahteve: Research Foundation (Flanders)
Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver (s) and``No Medical Care''Disease Impact in Belgium
J Bilcke, P Van Damme, P Beutels
Medical Decision Making 29 (1), 33-50, 2009
Zahteve: Research Foundation (Flanders)
Cost-effectiveness of respiratory syncytial virus disease prevention strategies: maternal vaccine versus seasonal or year-round monoclonal antibody program in Norwegian children
X Li, J Bilcke, L Vázquez Fernández, L Bont, L Willem, T Wisløff, M Jit, ...
The Journal of infectious diseases 226 (Supplement_1), S95-S101, 2022
Zahteve: European Commission
Sponsorship bias in base-case values and uncertainty bounds of health economic evaluations? A systematic review of herpes zoster vaccination
J Bilcke, F Verelst, P Beutels
Medical Decision Making 38 (6), 730-745, 2018
Zahteve: Research Foundation (Flanders)
Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds
B Ogunjimi, F Buntinx, S Bartholomeeusen, I Terpstra, L Willem, S Elli, ...
Journal of Infection 70 (2), 171-177, 2015
Zahteve: Research Foundation (Flanders)
Na voljo nekje: 38
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)
L Willem, F Verelst, J Bilcke, N Hens, P Beutels
BMC infectious diseases 17, 1-16, 2017
Zahteve: Research Foundation (Flanders)
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
Zahteve: Research Foundation (Flanders)
Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta …
S Zhang, LZ Akmar, F Bailey, BA Rath, M Alchikh, B Schweiger, ...
The Journal of infectious diseases 222 (Supplement_7), S680-S687, 2020
Zahteve: European Commission
Biomass production efficiency controlled by management in temperate and boreal ecosystems
M Campioli, S Vicca, S Luyssaert, J Bilcke, E Ceschia, FS Chapin III, ...
Nature geoscience 8 (11), 843-846, 2015
Zahteve: US Department of Energy, Research Foundation (Flanders), Natural Sciences …
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 …
X Li, L Willem, M Antillon, J Bilcke, M Jit, P Beutels
BMC medicine 18, 1-16, 2020
Zahteve: Research Foundation (Flanders), European Commission
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
J Bilcke, M Antillón, Z Pieters, E Kuylen, L Abboud, KM Neuzil, AJ Pollard, ...
The Lancet Infectious Diseases 19 (7), 728-739, 2019
Zahteve: Bill & Melinda Gates Foundation, Research Foundation (Flanders), National …
The health and economic burden of chickenpox and herpes zoster in Belgium
J Bilcke, B OGUNJIMI, C Marais, F De Smet, M Callens, K Callaert, ...
Epidemiology & Infection 140 (11), 2096-2109, 2012
Zahteve: Research Foundation (Flanders)
Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all
J Bilcke, S Coenen, P Beutels
PloS one 9 (7), e102634, 2014
Zahteve: Research Foundation (Flanders)
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
J Bilcke, P Beutels
Pharmacoeconomics 27, 281-297, 2009
Zahteve: Research Foundation (Flanders)
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low-and middle-income settings
M Antillón, J Bilcke, AD Paltiel, VE Pitzer
Vaccine 35 (27), 3506-3514, 2017
Zahteve: Bill & Melinda Gates Foundation, Research Foundation (Flanders)
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014
M Sabbe, N Berger, A Blommaert, B Ogunjimi, T Grammens, M Callens, ...
Eurosurveillance: European communicable disease bulletin/European …, 2016
Zahteve: Research Foundation (Flanders)
Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium?
VE Pitzer, J Bilcke, E Heylen, FW Crawford, M Callens, F De Smet, ...
Scientific reports 5 (1), 18585, 2015
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health, Research …
Case fatality rate of enteric fever in endemic countries: a systematic review and meta-analysis
Z Pieters, NJ Saad, M Antillón, VE Pitzer, J Bilcke
Clinical Infectious Diseases 67 (4), 628-638, 2018
Zahteve: Bill & Melinda Gates Foundation, Research Foundation (Flanders)
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
R Birger, M Antillón, J Bilcke, C Dolecek, G Dougan, AJ Pollard, ...
The Lancet Infectious Diseases 22 (5), 679-691, 2022
Zahteve: Bill & Melinda Gates Foundation, National Institute for Health Research, UK
Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium
J Bilcke, C Marais, B Ogunjimi, L Willem, N Hens, P Beutels
Vaccine 30 (3), 675-684, 2012
Zahteve: Research Foundation (Flanders)
Podatke o objavi in financiranju samodejno določi računalniški program